Ovarian regulators of gonadotropin secretion.
Great progress in the ovarian mechanisms that control gonadotrophin secretion in women has recently been achieved. Estradiol (E2) is the main component of the ovarian negative effect on basal gonadotropin secretion during the normal menstrual cycle. However, nonsteroidal substances such as inhibins and activins that can affect follicle-stimulating hormone (FSH) secretion in vitro may also participate in the control of FSH secretion in vivo. Recent evidence has shown that the ovaries also produce another nonsteroidal substance, named gonadotropin surge-attenuating factor (GnSAF), that specifically attenuates GnRH-induced LH secretion and the endogenous LH surge in superovulated women. It is possible that during the normal menstrual cycle GnSAF controls the amplitude of the midcycle LH surge by antagonizing the stimulating effect of E2 on the pituitary.
Messinis
I E
IE
Department of Obstetrics and Gynaecology, University of Thessalia, Medical School, Larissa, Greece.
D004958:Estradiol / Q000502:physiology; D005260:Female; D005640:Follicle Stimulating Hormone / Q000378:metabolism; D042341:Gonadal Hormones; D012739:Gonadal Steroid Hormones / Q000502:physiology; D006065:Gonadotropins, Pituitary / Q000378:metabolism*; D006801:Humans; D007265:Inhibins / Q000502:physiology; D007986:Luteinizing Hormone / Q000378:metabolism; D008597:Menstrual Cycle; D010053:Ovary / Q000502:physiology*; D011506:Proteins / Q000502:physiology
D042341:Gonadal Hormones; D012739:Gonadal Steroid Hormones; D006065:Gonadotropins, Pituitary; D011506:Proteins; C080538:attenuin; D004958:Estradiol; D007265:Inhibins; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone